| 摘要 |
FIELD: medicine. ^ SUBSTANCE: present invention refers to medicine, namely oncology, and concerns cerebral antitumourigenesis. That is ensured by introduction of therapeutically effective amount of integrin antagonist representing either v3 antibody, or v5 antibody, or combined v3 and v5 antibodies respectively. ^ EFFECT: method enables cerebral antitumourigenesis owing to inhibition of angiogenesis, and apoptosis of tumour cells. ^ 2 tbl, 9 dwg, 5 cl |
